Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation

NCT00016081 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Infection

Interventions

DRUG: ribavirin

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]